Impact of an Educational Tool on Quality of Life and Anxiety in Parents of Children With Nut Allergy
1 other identifier
interventional
98
1 country
1
Brief Summary
The number of young children with food allergy, in particular with nut allergy, is increasing worldwide. A diagnosis of nut allergy can cause much anxiety in parents. They worry about their child being exposed to nuts in foods when outside the home. This anxiety can lead to these young children being restricted from taking part in normal childhood activities. Last year, the investigators conducted a study Recording accidental allergic reactions in children's and teenagers (ReAACT) in which they surveyed over 500 children with food allergy attending our clinic, in order to learn more about their participation in social activities and their practices in relation to eating outside the home. In the present study, the investigators wish to build upon these results through using the findings to develop a programme to help to lessen the fear and anxiety experienced by parents of young children with newly diagnosed nut allergy. The investigators imagine that knowledge of how other families with children who have food allergy participate in activities involving food outside of the home might help newly diagnosed families. The investigators would like to know if parents of young children newly diagnosed with nut allergy would benefit from hearing this information. In order to do this, the investigators have developed a short online programme that parents can take part in, in their own homes. Content will focus on the day to day social activities of children with food allergy, based on the findings of the REAACT study. To help the investigators to measure the effectiveness of this programme on reducing anxiety and improving quality of life, they are asking all volunteer participants to complete 4 questionnaires. Two of these questionnaires will ask a parent to indicate 1) the impact of their child's nut allergy on their quality of life and 2) on their child's quality of life. The third questionnaire will ask about their level of anxiety. The fourth questionnaire will ask about their emotions and the coping strategies they use in the context of their child's food allergy. Participants will be randomized into 2 groups. Group 1 will take part in the online education session along with the usual education provided by the allergy team. The questionnaires will be completed online using only a study identifier number. This will ensure anonymity throughout the study. The only personal information that will be asked is parent's age group, whether they are a mother or father, their child's age and gender and whether they have any other allergies. Two weeks following the online educational session, Groups 1 and 2 will again complete the online questionnaires. The research question is to determine if the online educational session is effective at decreasing anxiety and improving quality of life in parents of young children with nut allergy. The outcomes are health related quality of life and level of anxiety. It is hoped that the findings will positively support parents, children and their families in Ireland who are living and managing nut allergy on a daily basis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Submitted
Initial submission to the registry
July 8, 2022
CompletedFirst Posted
Study publicly available on registry
July 14, 2022
CompletedJanuary 5, 2024
January 1, 2024
1 month
July 8, 2022
January 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Primary Outcome 1
Change in score in each group on Food allergy Quality of Life Questionnaire (FAQLQ) parental proxy form
4 weeks
Primary Outcome 2
Change in score in each group on Food Allergy Quality of Life (FAQOL) parental burden form
4 weeks
Primary Outcome 3
Change in score in each group on Stait and Trait anxiety inventory (STAI)
4 weeks
Secondary Outcomes (1)
Secondary Score
4 weeks
Study Arms (2)
educational Booklet
EXPERIMENTALReceive intervention- educational booklet describing the day to day social activities and eating out habits of children with established food allergy in Ireland
Routine education
ACTIVE COMPARATORThis group will receive routine education in the allergy group.
Interventions
An educational booklet giving information on social and eating out habits as well as reaction rates in food allergy Irish children.
Eligibility Criteria
You may qualify if:
- Parents of children between 6 and 36 months
- Parent of children with a new diagnosis of a nut allergy defined as a clinical reaction with a skin prick test (SPT) of \>3mm or sensitised with a SPT of \>7mm.
You may not qualify if:
- Parents who already had a child with a food allergy as parents would have well established coping mechanisms
- Participation in another research project
- Their food allergic child had another chronic condition that might cause anxieties in social environments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Health Ireland
Dublin, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miranda Crealey, MD
Children's Health Ireland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2022
First Posted
July 14, 2022
Study Start
May 25, 2021
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
January 5, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share